“Dire need for new treatments that work.”
Patients at the New York State Psychiatric Institute saw a marked reduction in symptoms with synthetic THC medication and psychological treatment specific to Obsessive Compulsive Disorder (OCD).
Researchers initially planned to have patients “smoke marijuana” using different concentrations of THC and CBD.
Instead, synthetic THC was used because “CBD and THC are not FDA-approved for treating OCD”, the study says.
Lead researcher Reilly R. Kayser, MD told Medscape there’s a “dire need for new treatments that work” and that synthetic THC seems to help patients learn how to extinguish fear, a hallmark of OCD.
THC drug Nabilone (Cesamet) is FDA-approved but only for specific conditions such as vomiting caused by chemotherapy.
The clinical trial Effects of Marijuana on Symptoms of Obsessive-Compulsive Disorder was completed in April 2019.
The results were published in the June 3, 2019 issue of Medscape Medical News following a presentation at the American Society of Clinical Psychopharmacology, May 30, 2019.